By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Approves First and Only Weekly Diabetes 2 Shot Therapy in the US
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > FDA Approves First and Only Weekly Diabetes 2 Shot Therapy in the US
BusinessNews

FDA Approves First and Only Weekly Diabetes 2 Shot Therapy in the US

BarbaraDuck
BarbaraDuck
Share
3 Min Read
SHARE

Bydureon took three tries to make it through approval with the FDA.  The active ingredient comes from a synthetic version of saliva from the Gila Monster.  I am imageBydureon took three tries to make it through approval with the FDA.  The active ingredient comes from a synthetic version of saliva from the Gila Monster.  I am imageoriginally from Arizona and I know what those are and way back in 2007 the talk was in the exploration of saliva with lizards.  Bydureon is not insulin and is not for people with diabetes type 1.  Byetta is the non extended version of the drug that has been around for a once a day injection and has been associated with acute pancreatitis, so I would guess the same warnings would apply here as well. 

Lizard spit and bongs – Medication Origins and Future

BYDUREON has been approved with a Risk Evaluation and Mitigation Strategy (REMS) and there are a number of post market requirements to assess the impact of the drug relative to thyroid cancer or heart disease as some rats in the testing phase had those issues. 

Jan. 27 (Bloomberg) — Amylin Pharmaceuticals Inc. and Alkermes Plc succeeded in their third attempt to gain U.S. clearance for Bydureon, a once-weekly version of Amylin’s diabetes shot.

The Food and Drug Administration approved the drug for adults with Type 2 diabetes, the agency said today in a letter posted on their website.

Bydureon is a long-acting form of Byetta, a twice-daily injection that San Diego-based Amylin developed with Eli Lilly & Co. in a partnership that ended last year. Amylin lost almost half its market value on Oct. 20, 2010, after the FDA rejected Bydureon for a second time and sought a study on cardiac effects. The companies refiled for approval last year after the trial didn’t tie the drug to dangerous heart-rhythm changes.image

The active ingredient in Byetta and Bydureon, known as exenatide, stimulates pancreas cells to produce insulin when blood sugar is high. It is a synthetic version of a substance found in the saliva of the Gila monster. Bydureon uses technology developed by Alkermes to slowly release exenatide into the bloodstream with one dose a week. The drug won European Commission approval in June.

http://www.businessweek.com/news/2012-01-28/amylin-alkermes-diabetes-drug-wins-approval-on-third-try.html

 

More Read

Beyond the Buzz: Scheduling Healthcare Tweets
Will Your Local Hospital Exist in 10 years? Should it?
Why Most Patients Don’t Make Referrals (and How to Fix That)
Hospital Robots Are on Their Way
Mobile Health Around the Globe (Bonus Post!): Six mHealth Companies Bringing Health Technology to Developing Countries

TAGGED:Bydureondiabetesgila monsterpharmaceuticals
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Image
BusinessHealth Reform

Who Will Be Uninsured Under ObamaCare?

March 26, 2011

Amid Budget Shortfall, Minnesota Hospitals Defend Spending on Economic Terms

May 28, 2011

There is No Such Thing as an “Unbundled” Medical Bill

November 28, 2011

Medical Device Companies: Avoid These Inbound Marketing Mistakes

November 4, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?